Flunarizine, an anti-migraine agent, impairs nitroxidergic nerve function in cerebral arteries

This publication has 19 references indexed in Scilit:

• Effect of the novel calcium antagonist AE0047 on responses of isolated dog blood vessels to vasoconstricting agents and to nerve stimulation.
  Folia Pharmacologica Japonica, 1995
• Inhibitory Effect of Cilnidipine on Vascular Sympathetic Neurotransmission and Subsequent Vasoconstriction in Spontaneously Hypertensive Rats
  The Japanese Journal of Pharmacology, 1995
• Flunarizine in Migraine: A Minireview
  Headache: The Journal of Head and Face Pain, 1991
• Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics
  Pain, 1989
• Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle.
  Proceedings of the National Academy of Sciences, 1987
• Flunarizine in The Prevention of Classical Migraine: A Placebo-Controlled Evaluation
  Cephalalgia, 1985
• Flunarizine A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use
  Drugs, 1984
• Flunarizine, a new preventive approach to migraine
  Clinical Neurology and Neurosurgery, 1984
• A Double‐blind Placebo‐controlled Prophylactic Study of Flunarizine (Sibelium®) in Migraine
  Headache: The Journal of Head and Face Pain, 1981
• Effect of the Calcium Antagonist, Nimodipine, on Cerebral Blood Flow and Metabolism in the Primate
  Journal of Cerebral Blood Flow & Metabolism, 1981